Exact Mass: 323.0585

Exact Mass Matches: 323.0585

Found 249 metabolites which its exact mass value is equals to given mass value 323.0585, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pirinixic acid

2-({4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl}sulfanyl)acetic acid

C14H14ClN3O2S (323.0495)


2-methylthioribosyl-trans-zeatin, also known as wy-14,643 or cxpta, is a member of the class of compounds known as aryl thioethers. Aryl thioethers are organosulfur compounds containing a thioether group that is substituted by an aryl group. 2-methylthioribosyl-trans-zeatin is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 2-methylthioribosyl-trans-zeatin can be found in common pea and common wheat, which makes 2-methylthioribosyl-trans-zeatin a potential biomarker for the consumption of these food products. CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9387; ORIGINAL_PRECURSOR_SCAN_NO 9382 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9350; ORIGINAL_PRECURSOR_SCAN_NO 9349 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4901; ORIGINAL_PRECURSOR_SCAN_NO 4897 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4896; ORIGINAL_PRECURSOR_SCAN_NO 4894 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9397; ORIGINAL_PRECURSOR_SCAN_NO 9396 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4984; ORIGINAL_PRECURSOR_SCAN_NO 4982 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9362; ORIGINAL_PRECURSOR_SCAN_NO 9360 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9288; ORIGINAL_PRECURSOR_SCAN_NO 9287 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4364; ORIGINAL_PRECURSOR_SCAN_NO 4363 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9321; ORIGINAL_PRECURSOR_SCAN_NO 9318 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4386; ORIGINAL_PRECURSOR_SCAN_NO 4382 CONFIDENCE standard compound; INTERNAL_ID 293; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4906; ORIGINAL_PRECURSOR_SCAN_NO 4904 Pirinixic acid (Wy-14643) is a potent agonist of PPARα, with EC50s of 0.63 μM, 32 μM for murine PPARα and PPARγ, and 5.0 μM, 60 μM, 35 μM for human PPARα, PPARγ and PPARδ, respectively.

   

Cytidine monophosphate

{[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C9H14N3O8P (323.0518)


Cytidine monophosphate, also known as 5-cytidylic acid and abbreviated CMP, is a nucleotide. It is an ester of phosphoric acid with the nucleoside cytidine. CMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase cytosine. Cytidine monophosphate (CMP) is derived from cytidine triphosphate (CTP) with subsequent loss of two phosphates. The synthesis of the pyrimidines CTP and UTP occurs in the cytoplasm and starts with the formation of carbamoyl phosphate from glutamine and CO2. Next, aspartate undergoes a condensation reaction with carbamoyl-phosphate to form orotic acid. In a subsequent cyclization reaction, the enzyme Aspartate carbamoyltransferase forms N-carbamoyl-aspartate which is converted into dihydroorotic acid by Dihydroorotase. The latter is converted to orotate by Dihydroorotate oxidase. Orotate is covalently linked with a phosphorylated ribosyl unit with Orotate phosphoribosyltransferase (aka "PRPP transferase") catalyzing reaction, yielding orotidine monophosphate (OMP). Orotidine-5-phosphate is decarboxylated by Orotidine-5-phosphate decarboxylase to form uridine monophosphate (UMP). UMP is phosphorylated by two kinases to uridine triphosphate (UTP) via two sequential reactions with ATP. CTP is subsequently formed by amination of UTP by the catalytic activity of CTP synthetase. Cytosine monophosphate (CMP) and uridine monophosphate (UMP) have been prescribed for the treatment of neuromuscular affections in humans. Patients treated with CMP/UMP recover from altered neurological functions. Additionally, the administration of CMP/UMP appears to favour the entry of glucose in the muscle and CMP/UMP may be important in maintaining the level of hepatic glycogen constant during exercise. [PMID:18663991]. Cytidine monophosphate, also known as cmp or cytidylic acid, is a member of the class of compounds known as pyrimidine ribonucleoside monophosphates. Pyrimidine ribonucleoside monophosphates are pyrimidine ribobucleotides with monophosphate group linked to the ribose moiety. Cytidine monophosphate is soluble (in water) and a moderately acidic compound (based on its pKa). Cytidine monophosphate can be found in a number of food items such as elliotts blueberry, small-leaf linden, orange mint, and malabar spinach, which makes cytidine monophosphate a potential biomarker for the consumption of these food products. Cytidine monophosphate can be found primarily in saliva, as well as throughout all human tissues. Cytidine monophosphate exists in all living species, ranging from bacteria to humans. In humans, cytidine monophosphate is involved in several metabolic pathways, some of which include cardiolipin biosynthesis cl(i-13:0/i-18:0/i-17:0/18:2(9z,11z)), cardiolipin biosynthesis cl(i-13:0/i-24:0/a-21:0/i-15:0), cardiolipin biosynthesis cl(i-13:0/i-22:0/i-20:0/i-15:0), and cardiolipin biosynthesis cl(i-12:0/a-17:0/i-20:0/a-21:0). Cytidine monophosphate is also involved in several metabolic disorders, some of which include beta ureidopropionase deficiency, MNGIE (mitochondrial neurogastrointestinal encephalopathy), UMP synthase deficiency (orotic aciduria), and dihydropyrimidinase deficiency. Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1]. Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1].

   

Cytidine 3'-monophosphate

{[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C9H14N3O8P (323.0518)


Cytidine 3-monophosphate (3-CMP), also known as 3-cytidylic acid or 3-cytidylate, belongs to the class of organic compounds known as pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. Cytidine 3-monophosphate has been identified in the human placenta (PMID: 32033212). Acquisition and generation of the data is financially supported in part by CREST/JST.

   

Cytidine 2'-phosphate

{[(3R,4R,5R)-2-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C9H14N3O8P (323.0518)


Cytidine 2-phosphate is a cytidine nucleotide containing a phosphate group esterified to C2 of the sugar moiety. Cytidine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration. [HMDB] Cytidine 2-phosphate is a cytidine nucleotide containing a phosphate group esterified to C2 of the sugar moiety. Cytidine 2-phosphate is a product of 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. 2,3-cyclic nucleotide 3-phosphodiesterase is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration.

   

NSK-850

Thenylchlor

C16H18ClNO2S (323.0747)


   

O-Ethyl O-(4-nitrophenyl) phenylphosphonothioate

Ethoxy-(4-nitrophenoxy)-phenyl-sulphanylidene-$l^{5}-phosphane

C14H14NO4PS (323.0381)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

   

Tazarotenic acid

6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylic acid

C19H17NO2S (323.098)


Tazarotenic acid is a metabolite of tazarotene. Tazarotene (marketed as Tazorac, Avage and Zorac) is a prescription topical retinoid sold as a cream or gel. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). It is commonly sold in two concentrations: 0.05\\% and 0.1\\%. Common side effects include worsening of acne, dry skin, itchiness, redness and in some cases extreme drying and cracking of skin. (Wikipedia)

   

Wy-14643

Pirinixic acid

C14H14ClN3O2S (323.0495)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D002273 - Carcinogens > D020025 - Peroxisome Proliferators D009676 - Noxae > D000963 - Antimetabolites D009676 - Noxae > D009153 - Mutagens Pirinixic acid (Wy-14643) is a potent agonist of PPARα, with EC50s of 0.63 μM, 32 μM for murine PPARα and PPARγ, and 5.0 μM, 60 μM, 35 μM for human PPARα, PPARγ and PPARδ, respectively.

   

Clomeprop

2-(3,5-dichloro-4-methylphenoxy)-N-phenylpropanamide

C16H15Cl2NO2 (323.048)


   

N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide

N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide

C15H11Cl2NO3 (323.0116)


Alda-1 is a potent and selective ALDH2 agonist, which activates wild-type ALDH2 and restores near wild-type activity to ALDH2*2.

   

desmethyladinazolam

{12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methanamine

C17H14ClN5 (323.0938)


desmethyladinazolam is a metabolite of adinazolam. Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. (Wikipedia)

   

Cytosine arabinose-5'-phosphate

{[3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic acid

C9H14N3O8P (323.0518)


Isolated from biol. sources, e.g. Phaseolus aureus (mung bean) seedlings

   

N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide

N-(2H-1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzene-1-carboximidic acid

C15H11Cl2NO3 (323.0116)


   

BULAN

1-chloro-4-[1-(4-chlorophenyl)-2-nitrobutyl]benzene

C16H15Cl2NO2 (323.048)


   

Dabsyl chloride

4-{2-[4-(dimethylamino)phenyl]diazen-1-yl}benzene-1-sulfonyl chloride

C14H14ClN3O2S (323.0495)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

   

Myo-inositol glutamate

3-amino-7a,8,9,10,11,11a-hexahydroxy-hexahydro-3H-1,7-benzodioxonine-2,6-dione

C11H17NO10 (323.0852)


   

58F70VH0HS

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H17NO4.HCl (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   

Lycorine

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H17NO4.HCl (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   
   

Aristoliukine C

Aristoliukine C

C18H13NO5 (323.0794)


   
   

Epoxyguinomicin A

Epoxyguinomicin A

C14H10ClNO6 (323.0197)


   

Norfissilandione

1,2-(Methylenedioxy)-9-methoxy-8,11-dioxo-6a,7-dehydroaporphine

C18H13NO5 (323.0794)


   

9-Methoxyaristolactam I

9-Methoxyaristololactam I

C18H13NO5 (323.0794)


   

Oxosarcophylline

Oxosarcophylline

C18H13NO5 (323.0794)


   

Decumbenine B

Decumbenine B

C18H13NO5 (323.0794)


   

Oxosarcocapnidine

Oxosarcocapnidine

C18H13NO5 (323.0794)


   

Indole-3-carboxylic acid beta-D-glucopyranosyl ester

Indole-3-carboxylic acid beta-D-glucopyranosyl ester

C15H17NO7 (323.1005)


   

metazachlor ESA

metazachlor ESA

C14H17N3O4S (323.094)


An organosulfonic acid that is 2-oxoethanesulfonic acid substituted by a (2,6-dimethylphenyl)(1H-pyrazol-1-ylmethyl)amino group at position 2. It is metabolite of the herbicide metazachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 705 CONFIDENCE standard compound; INTERNAL_ID 2061

   

2-chloro-N-(2-phenoxyphenyl)benzamide

2-chloro-N-(2-phenoxyphenyl)benzamide

C19H14ClNO2 (323.0713)


   

Maybridge3_001181

Maybridge3_001181

C18H14FN3O2 (323.107)


   

Maybridge3_000330

Maybridge3_000330

C18H13NO5 (323.0794)


   

2,4-dichlorobenzoic acid (6,7-dihydro-5H-benzofuran-4-ylideneamino) ester

2,4-dichlorobenzoic acid (6,7-dihydro-5H-benzofuran-4-ylideneamino) ester

C15H11Cl2NO3 (323.0116)


   
   
   

N-{[(1-Acetylpiperidin-4-yl)carbonyl]oxy}-4-chlorobenzenecarboximidamide

N-{[(1-Acetylpiperidin-4-yl)carbonyl]oxy}-4-chlorobenzenecarboximidamide

C15H18ClN3O3 (323.1037)


   

2-[[bis(4-fluorophenyl)methyl]sulfinyl]-N-methyl-acetamide

2-[[bis(4-fluorophenyl)methyl]sulfinyl]-N-methyl-acetamide

C16H15F2NO2S (323.0792)


   
   

Maybridge3_002649

Maybridge3_002649

C18H13NO5 (323.0794)


   
   
   
   

(E)-N-(isoferuloyl)-glutamic acid

(E)-N-(isoferuloyl)-glutamic acid

C15H17NO7 (323.1005)


   

(-)-7-N-methylmonobromophakellin

(-)-7-N-methylmonobromophakellin

C12H14BrN5O (323.0382)


   

Entadamide A glucoside

Entadamide A glucoside

C12H21NO7S (323.1039)


   
   
   
   
   

7,8-Dimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

7,8-Dimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

C18H13NO5 (323.0794)


   

tambjamine J acetate

tambjamine J acetate

C14H18BrN3O (323.0633)


   

oxocularidine

oxocularidine

C18H13NO5 (323.0794)


   
   
   
   

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)pentan-1-imine

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)pentan-1-imine

C11H21N3O4S2 (323.0973)


   

Lycorine HCl

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H18ClNO4 (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   

Entadamide A beta-D-glucopyranoside

Entadamide A beta-D-glucopyranoside

C12H21NO7S (323.1039)


Entadamide-A-β-D-glucopyranoside is one of the major components in the seeds of Entada phaseoloides. Entadamide-A-β-D-glucopyranoside has anti-complement activitie[1]. Entadamide-A-β-D-glucopyranoside is one of the major components in the seeds of Entada phaseoloides. Entadamide-A-β-D-glucopyranoside has anti-complement activitie[1].

   

Cytidine 5-monophosphate

((2R,3S,4S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate

C9H14N3O8P (323.0518)


A pyrimidine ribonucleoside 5-monophosphate having cytosine as the nucleobase. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1]. Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1].

   

3-CMP

CYTIDINE-2,3-MONOPHOSPHORIC ACID

C9H14N3O8P (323.0518)


A cytidine 3-phosphate compound with a monophosphate group at the 3-position. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1]. Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1].

   

CMP

Cytidine-5-monophosphate disodium salt,from Saccharomyces cerevisiae, crystalline

C9H14N3O8P (323.0518)


Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1]. Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1].

   

Cytidine monophosphate

Cytidine monophosphate

C9H14N3O8P (323.0518)


Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1]. Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1].

   

Cytidine-5-monophosphate

Cytidine-5-monophosphate

C9H14N3O8P (323.0518)


   
   

Metazachlor-ESA

Metazachlor-ESA

C14H17N3O4S (323.094)


CONFIDENCE standard compound; INTERNAL_ID 2061

   
   

Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylate

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester

C16H15F2NO4 (323.0969)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

(R)-Bromoenol lactone-d7

(R)-Bromoenol lactone-d7

C16H6D7BrO2 (323.0538)


   

(S)-Bromoenol lactone-d7

(S)-Bromoenol lactone-d7

C16H6D7BrO2 (323.0538)


   

Bromoenol lactone-d7

Bromoenol lactone-d7

C16H6D7BrO2 (323.0538)


   
   

N-Acetoacetcresidine sulfonic acid sodium salt

N-Acetoacetcresidine sulfonic acid sodium salt

C12H14NNaO6S (323.044)


   

N-ACETYL-ALPHA-D-GLUCOSAMINE 6-PHOSPHATE DISODIUM SALT

N-ACETYL-ALPHA-D-GLUCOSAMINE 6-PHOSPHATE DISODIUM SALT

C8H15NNaO9P (323.0382)


   

4-diazo-4-methoxydiphenylamine sulfate

4-diazo-4-methoxydiphenylamine sulfate

C13H13N3O5S (323.0576)


   

6-[(2-Chloro-5-fluoropyrimidin-4-yl)amino]-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one

6-[(2-Chloro-5-fluoropyrimidin-4-yl)amino]-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one

C13H11ClFN5O2 (323.0585)


   

1-[(4-methoxy-2-nitrophenyl)azo]-2-naphthol

1-[(4-methoxy-2-nitrophenyl)azo]-2-naphthol

C17H13N3O4 (323.0906)


   

2-(2-CHLORO-ACETYLAMINO)-4-PHENYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-4-PHENYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C15H14ClNO3S (323.0383)


   

(s)-p1-(3-mercapto-1-pyrrolidinyl)ethylidene]-(4-nitrophenyl)methyl ester, carbamic acid

(s)-p1-(3-mercapto-1-pyrrolidinyl)ethylidene]-(4-nitrophenyl)methyl ester, carbamic acid

C14H17N3O4S (323.094)


   

3-(Naphthalene-2-sulfonyl)-thiazolidine-2-carboxylic acid

3-(Naphthalene-2-sulfonyl)-thiazolidine-2-carboxylic acid

C14H13NO4S2 (323.0286)


   
   

1-PIPERIDINECARBOXYLIC ACID, 4-(5-CHLORO-2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-1-YL)-, ETHYL ESTER

1-PIPERIDINECARBOXYLIC ACID, 4-(5-CHLORO-2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-1-YL)-, ETHYL ESTER

C15H18ClN3O3 (323.1037)


   

1-(3-(TRIFLUOROMETHYL)BENZENESULFONYL)PROLINE

1-(3-(TRIFLUOROMETHYL)BENZENESULFONYL)PROLINE

C12H12F3NO4S (323.0439)


   

Benzenediazonium,2-methoxy-4-(phenylamino)-,sulfate(1;1)

Benzenediazonium,2-methoxy-4-(phenylamino)-,sulfate(1;1)

C13H13N3O5S (323.0576)


   

1-(3,4-Dichlorobenzyl)-4-piperidine-carboxylic acid hydrochloride

1-(3,4-Dichlorobenzyl)-4-piperidine-carboxylic acid hydrochloride

C13H16Cl3NO2 (323.0247)


   

2-methyl-1-(4-methylsulfanylphenyl)-5-phenylpyrrole-3-carboxylic acid

2-methyl-1-(4-methylsulfanylphenyl)-5-phenylpyrrole-3-carboxylic acid

C19H17NO2S (323.098)


   

Ethyl 5-(5-bromo-1H-indol-1-yl)pentanoate

Ethyl 5-(5-bromo-1H-indol-1-yl)pentanoate

C15H18BrNO2 (323.0521)


   

2-HYDROXY-5-(4-METHOXY-PHENYLSULFAMOYL)-BENZOIC ACID

2-HYDROXY-5-(4-METHOXY-PHENYLSULFAMOYL)-BENZOIC ACID

C14H13NO6S (323.0464)


   

2-[(4-fluorophenyl)sulfonylamino]-3-phenylpropanoic acid

2-[(4-fluorophenyl)sulfonylamino]-3-phenylpropanoic acid

C15H14FNO4S (323.0628)


   

1-diethoxyphosphorylsulfanyl-4-nitrobenzene

1-diethoxyphosphorylsulfanyl-4-nitrobenzene

C10H14NO7PS (323.0229)


   

ETHYL 3-AMINO-4-(ISOPROPYLSULFONYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLATE

ETHYL 3-AMINO-4-(ISOPROPYLSULFONYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLATE

C11H17NO4S3 (323.032)


   

4-BROMOTRIPHENYLAMINE

4-BROMOTRIPHENYLAMINE

C18H14BrN (323.031)


   

4-BENZOYLBENZOIC ACID SUCCINIMIDYL ESTER

4-BENZOYLBENZOIC ACID SUCCINIMIDYL ESTER

C18H13NO5 (323.0794)


   

1H-Indene-1,3(2H)-dione,2-benzo[f]quinolin-3-yl-

1H-Indene-1,3(2H)-dione,2-benzo[f]quinolin-3-yl-

C22H13NO2 (323.0946)


   

ethyl 2-amino-4-(biphenyl-4-yl)thiophene-3-carboxylate

ethyl 2-amino-4-(biphenyl-4-yl)thiophene-3-carboxylate

C19H17NO2S (323.098)


   

2,3-diacetyloxy-3-(1,3-benzothiazol-2-yl)propanoic acid

2,3-diacetyloxy-3-(1,3-benzothiazol-2-yl)propanoic acid

C14H13NO6S (323.0464)


   

2-amino-4-[3,5-bis(trifluoromethyl)phenyl]amino-1,3,5-triazine

2-amino-4-[3,5-bis(trifluoromethyl)phenyl]amino-1,3,5-triazine

C11H7F6N5 (323.0606)


   

2-Bromo-N,N-diphenylaniline

2-Bromo-N,N-diphenylaniline

C18H14BrN (323.031)


   

METHYL 3-(2-CARBOXY-VINYL)-5-METHANESULFONYL-1H-INDOLE-2-CARBOXYLATE

METHYL 3-(2-CARBOXY-VINYL)-5-METHANESULFONYL-1H-INDOLE-2-CARBOXYLATE

C14H13NO6S (323.0464)


   

creatine citrate

creatine citrate

C10H17N3O9 (323.0965)


   

2-((6-Methoxy-2-methyl-4-quinolinyl)thio)-1-phenylethanone

2-((6-Methoxy-2-methyl-4-quinolinyl)thio)-1-phenylethanone

C19H17NO2S (323.098)


   
   

n-acetylglucosamine 6-sulfate sodium salt

n-acetylglucosamine 6-sulfate sodium salt

C8H14NNaO9S (323.0287)


   

N-(5-aminopentyl)-2-nitrobenzenesulfonamide,hydrochloride

N-(5-aminopentyl)-2-nitrobenzenesulfonamide,hydrochloride

C11H18ClN3O4S (323.0706)


   

1-BOC-4-BROMO-3-FORMYLINDOLE

1-BOC-4-BROMO-3-FORMYLINDOLE

C14H14BrNO3 (323.0157)


   

1-BOC-5-BROMO-3-FORMYLINDOLE

1-BOC-5-BROMO-3-FORMYLINDOLE

C14H14BrNO3 (323.0157)


   

Potassium 1-Boc-indole-2-trifluoroborate

Potassium 1-Boc-indole-2-trifluoroborate

C13H14BF3KNO2 (323.0707)


   
   

3-Bromo-N,N-diphenylaniline

3-Bromo-N,N-diphenylaniline

C18H14BrN (323.031)


   

ETHYL 5-HYDROXY-8-ISOPROPYL-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

ETHYL 5-HYDROXY-8-ISOPROPYL-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C14H17N3O4S (323.094)


   

ETHYL 5-HYDROXY-2-(METHYLTHIO)-7-OXO-8-PROPYL-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

ETHYL 5-HYDROXY-2-(METHYLTHIO)-7-OXO-8-PROPYL-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C14H17N3O4S (323.094)


   

(5-(METHOXYCARBONYL)-1-TOSYL-1H-PYRROL-3-YL)BORONIC ACID

(5-(METHOXYCARBONYL)-1-TOSYL-1H-PYRROL-3-YL)BORONIC ACID

C13H14BNO6S (323.0635)


   
   
   

2,3-Dibromopropene

2,3-Dibromopropene

C6H17N3O10S (323.0635)


   

N-acetyl-d-glucosamine 6-phosphate disodium salt

D-Glucopyranose, 2-(acetylamino)-2-deoxy-, 6-(dihydrogen phosphate), disodium salt

C8H15NNaO9P (323.0382)


Glycogen Metabolism: In mammals, GlcNAc-6-P plays a key role in the synthesis of glycogen, a storage form of glucose in the body. It is formed from glucose-6-phosphate by the enzyme glucosamine-6-phosphate synthase. GlcNAc-6-P is then converted to UDP-N-acetylglucosamine (UDP-GlcNAc), which is essential for the addition of GlcNAc residues to the growing glycogen chain during glycogen synthesis. Pentose Phosphate Pathway (PPP): GlcNAc-6-P can enter the PPP, a metabolic pathway that operates parallel to glycolysis. In the PPP, it is involved in the production of NADPH, which is important for reductive biosynthesis and antioxidant defense, and ribose-5-phosphate, a precursor for nucleotide synthesis. Cell Wall Synthesis in Bacteria and Fungi: In certain bacteria and fungi, GlcNAc-6-P is a precursor for the synthesis of peptidoglycan and chitin, respectively. Peptidoglycan is a major component of the cell wall in bacteria, providing structural support and protection. Chitin, found in the cell walls of fungi and the exoskeletons of arthropods, also plays a structural role. Other Metabolic Roles: GlcNAc-6-P is also involved in the synthesis of other complex carbohydrates and glycoproteins. It serves as a precursor for the synthesis of hyaluronic acid and keratan sulfate, important components of connective tissues and the extracellular matrix. Regulation of Metabolic Pathways: The levels of GlcNAc-6-P can regulate the activity of key enzymes in glucose metabolism. For example, high levels of GlcNAc-6-P can inhibit the enzyme phosphofructokinase-1 (PFK-1), a key regulatory step in glycolysis, thereby modulating the flux of glucose through this pathway. D-Glucopyranose, 2-(acetylamino)-2-deoxy-, 6-(dihydrogen phosphate), disodium salt. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=102029-88-9 (retrieved 2024-08-06) (CAS RN: 102029-88-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

H-9 dihydrochloride

H-9 dihydrochloride

C11H15Cl2N3O2S (323.0262)


H-9 Dihydrochloride is a PKA (protein kinase) inhibitor. H-9 Dihydrochloride (10 μM) significantly reduces the excitatory response to 5-HT. H-9 Dihydrochloride also has a direct effect on pharyngeal activity. H-9 Dihydrochloride inhibits signal-transduction and cell growth in EGF (epidermal growth factor)-dependent epithelial cell lines[1][2][3].

   

9-BROMO-7-METHYL-2-MORPHOLINO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE

9-BROMO-7-METHYL-2-MORPHOLINO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE

C13H14BrN3O2 (323.0269)


   

7-methoxy-8-methyl-2-[3-(trifluoromethyl)pyrazol-1-yl]-1H-quinolin-4-one

7-methoxy-8-methyl-2-[3-(trifluoromethyl)pyrazol-1-yl]-1H-quinolin-4-one

C15H12F3N3O2 (323.0882)


   
   

MOLYBDENUM V ETHOXIDE

MOLYBDENUM V ETHOXIDE

C10H25MoO5 (323.0756)


   

2-[2-(PHENYLSULFONYL)ETHYLTHIO]NICOTINIC ACID

2-[2-(PHENYLSULFONYL)ETHYLTHIO]NICOTINIC ACID

C14H13NO4S2 (323.0286)


   

14H-benzo[c]benzo[4,5]thieno[2,3-a]carbazole

14H-benzo[c]benzo[4,5]thieno[2,3-a]carbazole

C22H13NS (323.0769)


   

N-(4-Bromophenyl)-4-biphenylamine

N-(4-Bromophenyl)-4-biphenylamine

C18H14BrN (323.031)


   

1-Cyclopropyl-7-8-difluoro-6-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester

1-Cyclopropyl-7-8-difluoro-6-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester

C16H15F2NO4 (323.0969)


   

Cyclopentylalbendazole sulfone

Cyclopentylalbendazole sulfone

C14H17N3O4S (323.094)


   

4-(6-benzoyl-1H-benzimidazol-2-yl)benzonitrile

4-(6-benzoyl-1H-benzimidazol-2-yl)benzonitrile

C21H13N3O (323.1059)


   

5H--Benzo-a-1-benzothieno-3-2--c-carbazole

5H--Benzo-a-1-benzothieno-3-2--c-carbazole

C22H13NS (323.0769)


   
   

(2s, 4r)-boc-gamma-mso-proline methyl ester

(2s, 4r)-boc-gamma-mso-proline methyl ester

C12H21NO7S (323.1039)


   

2-(2,4-dichlorophenoxy)-N-[(E)-pyridin-3-ylmethylideneamino]acetamide

2-(2,4-dichlorophenoxy)-N-[(E)-pyridin-3-ylmethylideneamino]acetamide

C14H11Cl2N3O2 (323.0228)


   

2-(2,4-dichlorophenoxy)-N-[(E)-pyridin-2-ylmethylideneamino]acetamide

2-(2,4-dichlorophenoxy)-N-[(E)-pyridin-2-ylmethylideneamino]acetamide

C14H11Cl2N3O2 (323.0228)


   
   

5-(Diethylsulfamoyl)-3-hydroxynaphthalene-2-carboxylic acid

5-(Diethylsulfamoyl)-3-hydroxynaphthalene-2-carboxylic acid

C15H17NO5S (323.0827)


   

Ethyl 5-hydroxy-1,2-dimethyl-4,6-dinitroindole-3-carboxylate

Ethyl 5-hydroxy-1,2-dimethyl-4,6-dinitroindole-3-carboxylate

C13H13N3O7 (323.0753)


   

3-[(5,6-Dimethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

3-[(5,6-Dimethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

C16H13N5OS (323.0841)


   

N-(2-tert-butyl-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl)-2-thiophenecarboxamide

N-(2-tert-butyl-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl)-2-thiophenecarboxamide

C14H17N3O2S2 (323.0762)


   

3-[(6-Ethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

3-[(6-Ethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

C16H13N5OS (323.0841)


   

2-[(6-Fluoro-1,3-benzothiazol-2-yl)amino]-4-thiazolecarboxylic acid ethyl ester

2-[(6-Fluoro-1,3-benzothiazol-2-yl)amino]-4-thiazolecarboxylic acid ethyl ester

C13H10FN3O2S2 (323.0198)


   

N-(1,3-dioxo-5-isoindolyl)-1,3-benzothiazole-6-carboxamide

N-(1,3-dioxo-5-isoindolyl)-1,3-benzothiazole-6-carboxamide

C16H9N3O3S (323.0365)


   

Tolcapone 5-amino-3-O-sulfate

Tolcapone 5-amino-3-O-sulfate

C14H13NO6S (323.0464)


   

4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)picolinic acid

4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)picolinic acid

C14H8ClF2N3O2 (323.0273)


   

5-Amino-5-deoxyuridine-2-phosphate

5-Amino-5-deoxyuridine-2-phosphate

C9H14N3O8P (323.0518)


   
   

(2R,4R)-2-[(4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-3-methyl-1,3-thiazolidine-4-carboxylate

(2R,4R)-2-[(4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-3-methyl-1,3-thiazolidine-4-carboxylate

C14H15N2O3S2- (323.0524)


   

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(4-methylsulfanylbutyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(4-methylsulfanylbutyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

C11H21N3O4S2 (323.0973)


   

5-amino-7a,8,9,10,11,11a-hexahydroxy-4,5,8,9,10,11-hexahydro-3H-benzo[b][1,4]dioxonine-2,6-dione

5-amino-7a,8,9,10,11,11a-hexahydroxy-4,5,8,9,10,11-hexahydro-3H-benzo[b][1,4]dioxonine-2,6-dione

C11H17NO10 (323.0852)


   

2-(2-Fluorophenyl)-5-phenyl-4-thieno[2,3-d][1,3]oxazinone

2-(2-Fluorophenyl)-5-phenyl-4-thieno[2,3-d][1,3]oxazinone

C18H10FNO2S (323.0416)


   

3-[4-(2-Furanylmethyl)-5-sulfanylidene-1,2,4-triazolidin-3-ylidene]-2-naphthalenone

3-[4-(2-Furanylmethyl)-5-sulfanylidene-1,2,4-triazolidin-3-ylidene]-2-naphthalenone

C17H13N3O2S (323.0728)


   

3-Pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester

3-Pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester

C17H13N3O4 (323.0906)


   

3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5-thione

3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5-thione

C13H11ClFN5S (323.0408)


   

1-Ethyl-3-[[2-[(1-methyl-2-benzimidazolyl)thio]-1-oxoethyl]amino]thiourea

1-Ethyl-3-[[2-[(1-methyl-2-benzimidazolyl)thio]-1-oxoethyl]amino]thiourea

C13H17N5OS2 (323.0874)


   

[(Z)-6,7-dihydro-5H-1-benzofuran-4-ylideneamino] 2,4-dichlorobenzoate

[(Z)-6,7-dihydro-5H-1-benzofuran-4-ylideneamino] 2,4-dichlorobenzoate

C15H11Cl2NO3 (323.0116)


   

4-(4-Bromophenyl)-2-(1-piperazinyl)thiazole

4-(4-Bromophenyl)-2-(1-piperazinyl)thiazole

C13H14BrN3S (323.0092)


   

4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide

4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide

C16H18FNO3S (323.0991)


   

D-glucosyl indole-3-carboxylate

D-glucosyl indole-3-carboxylate

C15H17NO7 (323.1005)


An O-acyl carbohydrate obtained by formal condensation of the carboxy group of indole-3-carboxylic acid with the anomeric hydroxy group of D-glucose.

   

2-(4-methyl-1-piperazinyl)-N-(5-thiophen-2-yl-1,3,4-thiadiazol-2-yl)acetamide

2-(4-methyl-1-piperazinyl)-N-(5-thiophen-2-yl-1,3,4-thiadiazol-2-yl)acetamide

C13H17N5OS2 (323.0874)


   

1-(2,3-Dihydroindol-1-yl)-2-[[3-(methylthio)-1,2,4-thiadiazol-5-yl]thio]ethanone

1-(2,3-Dihydroindol-1-yl)-2-[[3-(methylthio)-1,2,4-thiadiazol-5-yl]thio]ethanone

C13H13N3OS3 (323.0221)


   

N-benzoyl-2-phenyl-4-thiazolecarbohydrazide

N-benzoyl-2-phenyl-4-thiazolecarbohydrazide

C17H13N3O2S (323.0728)


   

6-Azathymidine 5-monophosphate

6-Azathymidine 5-monophosphate

C9H14N3O8P (323.0518)


A N-glycosyl-1,2,4-triazine that is the 6-aza analogue of thymidine 5-monophosphate.

   

2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide

2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide

C16H18ClNO4 (323.0924)


   

5-[(4-Fluorophenyl)methylamino]-2-(2-methoxyphenyl)-4-oxazolecarbonitrile

5-[(4-Fluorophenyl)methylamino]-2-(2-methoxyphenyl)-4-oxazolecarbonitrile

C18H14FN3O2 (323.107)


   

3-(1-benzothiophen-3-yl)-4-(2-methylphenyl)-1H-1,2,4-triazole-5-thione

3-(1-benzothiophen-3-yl)-4-(2-methylphenyl)-1H-1,2,4-triazole-5-thione

C17H13N3S2 (323.0551)


   

2-thiophen-2-yl-N-(thiophen-2-ylmethyl)-4-quinazolinamine

2-thiophen-2-yl-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C17H13N3S2 (323.0551)


   

6-Azauridine 5-phosphate

6-Azauridine 5-phosphate

C8H10N3O9P-2 (323.0155)


   

2-Amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate

2-Amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate

C18H15N2O4- (323.1032)


   

2-(1H-benzimidazol-2-ylmethoxymethyl)-6-nitro-1H-benzimidazole

2-(1H-benzimidazol-2-ylmethoxymethyl)-6-nitro-1H-benzimidazole

C16H13N5O3 (323.1018)


   

2-Thiophenecarboxylic acid [3-methyl-1-oxo-1-(thiophen-2-ylmethylamino)butan-2-yl] ester

2-Thiophenecarboxylic acid [3-methyl-1-oxo-1-(thiophen-2-ylmethylamino)butan-2-yl] ester

C15H17NO3S2 (323.065)


   

Atromentin(1-)

Atromentin(1-)

C18H11O6- (323.0556)


An organic anion that is the conjugate base of atromentin, obtained from the deprotonation of one of the hydroxy groups of the 1,4-benzoquinone moiety. It is the major species at pH 7.3.

   

(2-Morpholin-4-ylphenyl) 1-methylimidazole-4-sulonate

(2-Morpholin-4-ylphenyl) 1-methylimidazole-4-sulonate

C14H17N3O4S (323.094)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester

C16H15F2NO4 (323.0969)


   

(2S)-2-(2-chloro-7-methylquinolin-3-yl)-2,3-dihydro-1H-quinazolin-4-one

(2S)-2-(2-chloro-7-methylquinolin-3-yl)-2,3-dihydro-1H-quinazolin-4-one

C18H14ClN3O (323.0825)


   

[(2S,3R,4R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2S,3R,4R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C9H14N3O8P (323.0518)


   

5-Cytidylic acid

5-Cytidylic acid

C9H14N3O8P (323.0518)


COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1]. Cytidine 5'-monophosphate (5'-Cytidylic acid) is a nucleotide which is used as a monomer in RNA. Cytidine 5'-monophosphate consists of the nucleobase cytosine, the pentose sugar ribose, and the phosphate group[1].

   

2-CMP

2-Cytidylic acid

C9H14N3O8P (323.0518)


   

Tazarotenic acid

Tazarotenic acid

C19H17NO2S (323.098)


   

2-(3,5-dichloro-4-methylphenoxy)-N-phenylpropanamide

2-(3,5-dichloro-4-methylphenoxy)-N-phenylpropanamide

C16H15Cl2NO2 (323.048)


   

EPN

O-Ethyl O-(4-nitrophenyl) phenylphosphonothioate

C14H14NO4PS (323.0381)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

   

5-Cytidylic acid, homopolymer

Cytosine arabinoside monophosphate

C9H14N3O8P (323.0518)


   
   

Midaglizole (hydrochloride)

Midaglizole (hydrochloride)

C16H19Cl2N3 (323.0956)


Midaglizole hydrochloride ((±)-DG5128, DG5128) is a potent α2-adrenoceptor antagonist. Midaglizole hydrochloride is a hypoglycemic agent. Midaglizole hydrochloride increases blood pressure and reduces blood glucose levels in vivo[1][2][3]. Midaglizole hydrochloride ((±)-DG5128, DG5128) is a potent α2-adrenoceptor antagonist. Midaglizole hydrochloride is a hypoglycemic agent. Midaglizole hydrochloride increases blood pressure and reduces blood glucose levels in vivo[1][2][3].

   

SCH-23390 (hydrochloride)

SCH-23390 (hydrochloride)

C17H19Cl2NO (323.0844)


SCH-23390 hydrochloride (R-(+)-SCH-23390 hydrochloride) is a potent and selective dopamine D1-like receptor antagonist with Kis of 0.2 nM and 0.3 nM for the D1 and D5 receptor, respectively. SCH-23390 hydrochloride is a potent and high efficacy human 5-HT2C receptor agonist with a Ki of 9.3 nM. SCH-23390 hydrochloride also binds with high affinity to the 5-HT2 and 5-HT1C receptors. SCH-23390 hydrochloride inhibits G protein-coupled inwardly rectifying potassium (GIRK) channels with an IC50 of 268 nM[1][2][3].

   

TASP0415914

TASP0415914

C13H17N5O3S (323.1052)


TASP0415914 is a potent and orally active PI3Kγ inhibitor with an IC50 of 29 nM. TASP0415914 also shows potent Akt inhibitory activities with an IC50 of 294 nM. TASP0415914 can be used for inflammatory diseases research[1].

   

17-hydroxy-4,5-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

17-hydroxy-4,5-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

C18H13NO5 (323.0794)


   

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(2-methylpropyl)amine

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(2-methylpropyl)amine

C14H18BrN3O (323.0633)


   

(12r)-18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

(12r)-18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

C18H13NO5 (323.0794)


   

6-methoxy-aristoloactam

NA

C18H13NO5 (323.0794)


{"Ingredient_id": "HBIN012515","Ingredient_name": "6-methoxy-aristoloactam","Alias": "NA","Ingredient_formula": "C18H13NO5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31526","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

9-methoxyaristolactam i

NA

C18H13NO5 (323.0794)


{"Ingredient_id": "HBIN014127","Ingredient_name": "9-methoxyaristolactam i","Alias": "NA","Ingredient_formula": "C18H13NO5","Ingredient_Smile": "COC1=CC=CC2=C3C4=C(C(=C21)OC)NC(=O)C4=CC5=C3OCO5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13835","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

{[(5z)-5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}((2s)-butan-2-yl)amine

{[(5z)-5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}((2s)-butan-2-yl)amine

C14H18BrN3O (323.0633)


   

12,14-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

12,14-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C18H13NO5 (323.0794)


   

(2z)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

(2z)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

3-chloro-2-hydroxy-n-[(1s,6r)-6-(hydroxymethyl)-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

3-chloro-2-hydroxy-n-[(1s,6r)-6-(hydroxymethyl)-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

C14H10ClNO6 (323.0197)


   

14,15-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

14,15-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C18H13NO5 (323.0794)


   

(2s)-2-{[(2e)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

(2s)-2-{[(2e)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

C15H17NO7 (323.1005)


   

({3'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylpropyl)amine

({3'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylpropyl)amine

C14H18BrN3O (323.0633)


   

({5-hydroxy-2-[(1z)-2-hydroxy-2-[(e)-[(1e)-2-(4-hydroxyphenyl)ethenyl]-c-hydroxycarbonimidoyl]eth-1-en-1-yl]phenyl}imino)methyl

({5-hydroxy-2-[(1z)-2-hydroxy-2-[(e)-[(1e)-2-(4-hydroxyphenyl)ethenyl]-c-hydroxycarbonimidoyl]eth-1-en-1-yl]phenyl}imino)methyl

C18H15N2O4 (323.1032)


   

4-bromo-n-[3-(2-imino-3-methyl-1h-imidazol-4-yl)prop-2-en-1-yl]-1h-pyrrole-2-carboxamide

4-bromo-n-[3-(2-imino-3-methyl-1h-imidazol-4-yl)prop-2-en-1-yl]-1h-pyrrole-2-carboxamide

C12H14BrN5O (323.0382)


   

(10r)-4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

(10r)-4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

15-hydroxy-4,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-11,12-dione

15-hydroxy-4,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-11,12-dione

C18H13NO5 (323.0794)


   

4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

3-(methylsulfanyl)-n-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

3-(methylsulfanyl)-n-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

{[(5z)-5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}(2-methylpropyl)amine

{[(5z)-5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}(2-methylpropyl)amine

C14H18BrN3O (323.0633)


   

3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

C18H13NO5 (323.0794)


   

4-bromo-n-[(2z)-3-(2-imino-3-methyl-1h-imidazol-4-yl)prop-2-en-1-yl]-1h-pyrrole-2-carboxamide

4-bromo-n-[(2z)-3-(2-imino-3-methyl-1h-imidazol-4-yl)prop-2-en-1-yl]-1h-pyrrole-2-carboxamide

C12H14BrN5O (323.0382)


   

(5-{2h-[1,3]dioxolo[4,5-f]isoquinolin-8-yl}-2h-1,3-benzodioxol-4-yl)methanol

(5-{2h-[1,3]dioxolo[4,5-f]isoquinolin-8-yl}-2h-1,3-benzodioxol-4-yl)methanol

C18H13NO5 (323.0794)


   

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylpropyl)amine

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylpropyl)amine

C14H18BrN3O (323.0633)


   

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(sec-butyl)amine

({5'-bromo-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(sec-butyl)amine

C14H18BrN3O (323.0633)


   

17-hydroxy-5,6-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,10,12,14,16-octaen-9-one

17-hydroxy-5,6-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,10,12,14,16-octaen-9-one

C18H13NO5 (323.0794)


   

(2s)-2-{[(2z)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

(2s)-2-{[(2z)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

C15H17NO7 (323.1005)


   

2-(hydroxymethyl)-11-iminobenzo[b]fluorene-4,5,9,10-tetrol

2-(hydroxymethyl)-11-iminobenzo[b]fluorene-4,5,9,10-tetrol

C18H13NO5 (323.0794)


   

14,16-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

14,16-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C18H13NO5 (323.0794)


   

[(2r,3s,4r,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

[(2r,3s,4r,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

C9H14N3O8P (323.0518)


   

3-chloro-2-hydroxy-n-[6-(hydroxymethyl)-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

3-chloro-2-hydroxy-n-[6-(hydroxymethyl)-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

C14H10ClNO6 (323.0197)


   

2-{[1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

2-{[1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

C15H17NO7 (323.1005)


   

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),12,14(19),16-hexaene-15,18-dione

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),12,14(19),16-hexaene-15,18-dione

C18H13NO5 (323.0794)


   

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),8,12,14(19),16-hexaene-15,18-dione

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),8,12,14(19),16-hexaene-15,18-dione

C18H13NO5 (323.0794)


   

4-hydroxy-5,17-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

4-hydroxy-5,17-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

C18H13NO5 (323.0794)


   

(2e)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

(2e)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

(10s)-5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

(10s)-5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1h-indole-3-carboxylate

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1h-indole-3-carboxylate

C15H17NO7 (323.1005)